P23458 (JAK1_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase JAK1 UniProtKBInterProSTRINGInteractive Modelling
1154 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
49 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| STRUCTURE OF INTERFERON LAMBDA 1 RECEPTOR WITH HUMAN KINASE JAK1 |
Heteromer Q8IU57; | |||||
| Assess | ||||||
| Structure of human JAK1 FERM/SH2 in complex with IFNLR1/IL10RA chimera |
Heteromer Q13651; Q8IU57; | |||||
| Assess | ||||||
| Structure of human JAK1 FERM/SH2 in complex with IFN lambda receptor |
Heteromer Q8IU57; | 1×CIT; | ||||
| Assess | ||||||
| Crystal structure of inhibitory protein SOCS1 in complex with JAK1 kinase domain |
Heteromer B6RCQ2; | 1×ADP; 2×MG; 3×EDO; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of PTP1B D181A/Q262A phosphatase domain in complex with a JAK1 activation loop ph… |
Heteromer P18031; | 1×PO4; 2×TRS; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 26 | homo-2-mer | 2×0NT; 1×PEG; | ||||
| Assess | ||||||
| Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class | homo-2-mer | 2×KHE; | ||||
| Assess | ||||||
| Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class | homo-2-mer | 2×KGZ; | ||||
| Assess | ||||||
| Crystal structure of JAK1 in complex with peficitinib | homo-2-mer | 2×9T6; | ||||
| Assess | ||||||
| Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class | homo-2-mer | 2×KH5; | ||||
| Assess | ||||||
| Human jak1 kinase domain in complex with compound 7 | monomer | 1×BFK; | ||||
| Assess | ||||||
| JAK1 complexed with compound 28 | monomer | 1×B7V; | ||||
| Assess | ||||||
| Human jak1 kinase domain in complex with inhibitor | monomer | 1×LKT; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with the inhibitor TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-… | monomer | 1×1J5; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 49 | monomer | 1×0NL; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 34 | monomer | 1×15T; | ||||
| Assess | ||||||
| HUMAN JAK1 IN COMPLEX WITH LASW1393 | monomer | 1×GYQ; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 20 | monomer | 1×0Q2; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with the inhibitor (TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5… | monomer | 1×1J6; | ||||
| Assess | ||||||
| Jak1 complex with 4-[(4-aminocyclohexyl)amino]-3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one | monomer | 1×66P; | ||||
| Assess | ||||||
| The Jak1 kinase domain in complex with inhibitor | monomer | 1×JAK; 5×EDO; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 72 | monomer | 1×0UJ; | ||||
| Assess | ||||||
| Human jak1 kinase domain in complex with inhibitor | monomer | 1×LKQ; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 39 | monomer | 2×GOL; 1×KEV; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 56 | monomer | 1×KF1; | ||||
| Assess | ||||||
| Human jak1 kinase domain in complex with inhibitor | monomer | 1×EYQ; | ||||
| Assess | ||||||
| Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class | monomer | 1×KH8; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 54 | monomer | 1×KF4; 1×GOL; | ||||
| Assess | ||||||
| Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class | monomer | 1×KHH; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 38 | monomer | 1×KEY; 2×GOL; | ||||
| Assess | ||||||
| Crystal structures of JAK1 and JAK2 inhibitor complexes | monomer | 1×MI1; | ||||
| Assess | ||||||
| Crystal structures of JAK1 and JAK2 inhibitor complexes | monomer | 1×IZA; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 30 | monomer | 2×0NH; | ||||
| Assess | ||||||
| The Jak1 kinase domain in complex with inhibitor | monomer | 1×C5I; | ||||
| Assess | ||||||
| Human JAK1 kinase in complex with compound 30 at 2.30 Angstroms resolution | monomer | 1×PEG; 1×5JG; | ||||
| Assess | ||||||
| Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity | monomer | 1×NTQ; | ||||
| Assess | ||||||
| JAK1 kinase (JH1 domain) in complex with compound 6 | monomer | 1×1Q4; | ||||
| Assess | ||||||
| The Jak1 kinase domain in complex with compound 37 | monomer | 1×1Q3; | ||||
| Assess | ||||||
| Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity | monomer | 1×NTW; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 15 | monomer | 1×KEJ; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 21 | monomer | 1×KEP; 1×GOL; | ||||
| Assess | ||||||
| Structure of the human JAK1 kinase domain with compound 20 | monomer | 1×KES; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of JAK1 in complex with compound 25 | monomer | 1×D7D; | ||||
| Assess | ||||||
| Crystal structure of JAK1 kinase with compound 10 | monomer | 1×R4S; | ||||
| Assess | ||||||
| Crystal structure of JAK1 in complex with PF-4950736 | monomer | 1×6TE; | ||||
| Assess | ||||||
| Jak1 with compound 23 | monomer | 1×G4J; | ||||
| Assess | ||||||
| Crystal structure of the apo Jak1 pseudokinase domain | monomer | |||||
| Assess | ||||||
| Crystal structure of JAK1 in complex with ADP | monomer | 1×ADP; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of the V658F apo Jak1 pseudokinase domain | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8ewy.1.B | monomer | 0.74 | 1×ADN; | 94.53 | ||
| Assess | ||||||
| 7t6f.1.A | monomer | 0.73 | 1×ADN; 1×ADP; | 94.53 | ||
| Assess | ||||||
| 4oli.1.A | monomer | 0.72 | 55.33 | |||
| Assess | ||||||